No  ||| S:0 E:3 ||| DT
differences  ||| S:3 E:15 ||| NNS
in  ||| S:15 E:18 ||| IN
support  ||| S:18 E:26 ||| NN
of  ||| S:26 E:29 ||| IN
thrombin  ||| S:29 E:38 ||| JJ
generation  ||| S:38 E:49 ||| NN
by  ||| S:49 E:52 ||| IN
neonatal  ||| S:52 E:61 ||| NN
or  ||| S:61 E:64 ||| CC
adult  ||| S:64 E:70 ||| NN
platelets  ||| S:70 E:80 ||| NN
Newborns  ||| S:80 E:89 ||| NNS
have ||| S:89 E:93 ||| VBP
,  ||| S:93 E:95 ||| ,
despite  ||| S:95 E:103 ||| IN
low  ||| S:103 E:107 ||| JJ
clotting  ||| S:107 E:116 ||| JJ
factors  ||| S:116 E:124 ||| NNS
and  ||| S:124 E:128 ||| CC
poor  ||| S:128 E:133 ||| JJ
in  ||| S:133 E:136 ||| IN
vitro  ||| S:136 E:142 ||| JJ
platelet  ||| S:142 E:151 ||| JJ
function ||| S:151 E:159 ||| NN
,  ||| S:159 E:161 ||| ,
a  ||| S:161 E:163 ||| DT
well  ||| S:163 E:168 ||| RB
functioning  ||| S:168 E:180 ||| VBG
hemostasis ||| S:180 E:190 ||| NNS
.  ||| S:190 E:192 ||| .
The  ||| S:192 E:196 ||| DT
reason  ||| S:196 E:203 ||| NN
for  ||| S:203 E:207 ||| IN
this  ||| S:207 E:212 ||| DT
is  ||| S:212 E:215 ||| VBZ
still  ||| S:215 E:221 ||| RB
not  ||| S:221 E:225 ||| RB
completely  ||| S:225 E:236 ||| RB
clear ||| S:236 E:241 ||| JJ
.  ||| S:241 E:243 ||| .
The  ||| S:243 E:247 ||| DT
aim  ||| S:247 E:251 ||| NN
of  ||| S:251 E:254 ||| IN
our  ||| S:254 E:258 ||| PRP$
study  ||| S:258 E:264 ||| NN
was  ||| S:264 E:268 ||| VBD
to  ||| S:268 E:271 ||| TO
investigate  ||| S:271 E:283 ||| VB
whether  ||| S:283 E:291 ||| IN
phospholipids  ||| S:291 E:305 ||| NN
in  ||| S:305 E:308 ||| IN
neonatal  ||| S:308 E:317 ||| JJ
platelets  ||| S:317 E:327 ||| NNS
differ  ||| S:327 E:334 ||| VBP
from  ||| S:334 E:339 ||| IN
those  ||| S:339 E:345 ||| DT
in  ||| S:345 E:348 ||| IN
adult  ||| S:348 E:354 ||| NN
platelets  ||| S:354 E:364 ||| NN
in  ||| S:364 E:367 ||| IN
their  ||| S:367 E:373 ||| PRP$
total  ||| S:373 E:379 ||| JJ
amount ||| S:379 E:385 ||| NN
,  ||| S:385 E:387 ||| ,
in  ||| S:387 E:390 ||| IN
their  ||| S:390 E:396 ||| PRP$
exposure  ||| S:396 E:405 ||| NN
on  ||| S:405 E:408 ||| IN
the  ||| S:408 E:412 ||| DT
platelet  ||| S:412 E:421 ||| JJ
surface ||| S:421 E:428 ||| NN
,  ||| S:428 E:430 ||| ,
and  ||| S:430 E:434 ||| CC
their  ||| S:434 E:440 ||| PRP$
effect  ||| S:440 E:447 ||| NN
on  ||| S:447 E:450 ||| IN
thrombin  ||| S:450 E:459 ||| JJ
generation  ||| S:459 E:470 ||| NN
( ||| S:470 E:471 ||| -LRB-
TG ||| S:471 E:473 ||| NNP
) ||| S:473 E:474 ||| -RRB-
.  ||| S:474 E:476 ||| .
Clotting  ||| S:476 E:485 ||| JJ
times  ||| S:485 E:491 ||| NNS
of  ||| S:491 E:494 ||| IN
newborn  ||| S:494 E:502 ||| NN
and  ||| S:502 E:506 ||| CC
adult  ||| S:506 E:512 ||| JJ
platelet-rich  ||| S:512 E:526 ||| JJ
plasma  ||| S:526 E:533 ||| NN
were  ||| S:533 E:538 ||| VBD
measured ||| S:538 E:546 ||| VBN
.  ||| S:546 E:548 ||| .
Effect  ||| S:548 E:555 ||| NN
of  ||| S:555 E:558 ||| IN
newborn  ||| S:558 E:566 ||| NN
and  ||| S:566 E:570 ||| CC
adult  ||| S:570 E:576 ||| NN
platelets  ||| S:576 E:586 ||| NN
on  ||| S:586 E:589 ||| IN
TG  ||| S:589 E:592 ||| NNP
was  ||| S:592 E:596 ||| VBD
measured  ||| S:596 E:605 ||| VBN
by  ||| S:605 E:608 ||| IN
means  ||| S:608 E:614 ||| NNS
of  ||| S:614 E:617 ||| IN
CAT  ||| S:617 E:621 ||| NNP
( ||| S:621 E:622 ||| -LRB-
calibrated  ||| S:622 E:633 ||| FW
automated  ||| S:633 E:643 ||| FW
thrombography ||| S:643 E:656 ||| FW
) ||| S:656 E:657 ||| -RRB-
.  ||| S:657 E:659 ||| .
In  ||| S:659 E:662 ||| IN
addition ||| S:662 E:670 ||| NN
,  ||| S:670 E:672 ||| ,
the  ||| S:672 E:676 ||| DT
effect  ||| S:676 E:683 ||| NN
of  ||| S:683 E:686 ||| IN
newborn  ||| S:686 E:694 ||| NN
and  ||| S:694 E:698 ||| CC
adult  ||| S:698 E:704 ||| NN
platelets  ||| S:704 E:714 ||| NN
with  ||| S:714 E:719 ||| IN
or  ||| S:719 E:722 ||| CC
without  ||| S:722 E:730 ||| IN
stimulation  ||| S:730 E:742 ||| NN
by  ||| S:742 E:745 ||| IN
ionophor  ||| S:745 E:754 ||| NN
on  ||| S:754 E:757 ||| IN
TG  ||| S:757 E:760 ||| NNP
was  ||| S:760 E:764 ||| VBD
measured  ||| S:764 E:773 ||| VBN
in  ||| S:773 E:776 ||| IN
a  ||| S:776 E:778 ||| DT
purified  ||| S:778 E:787 ||| JJ
prothrombinase  ||| S:787 E:802 ||| JJ
complex ||| S:802 E:809 ||| NN
.  ||| S:809 E:811 ||| .
Phosphatidylserine-exposure  ||| S:811 E:839 ||| NNP
( ||| S:839 E:840 ||| -LRB-
PS ||| S:840 E:842 ||| NNP
)  ||| S:842 E:844 ||| -RRB-
of  ||| S:844 E:847 ||| IN
newborn  ||| S:847 E:855 ||| NN
and  ||| S:855 E:859 ||| CC
adult  ||| S:859 E:865 ||| NN
platelets  ||| S:865 E:875 ||| NNS
was  ||| S:875 E:879 ||| VBD
measured  ||| S:879 E:888 ||| VBN
by  ||| S:888 E:891 ||| IN
flow  ||| S:891 E:896 ||| NN
cytometry  ||| S:896 E:906 ||| NN
of  ||| S:906 E:909 ||| IN
annexin  ||| S:909 E:917 ||| JJ
V  ||| S:917 E:919 ||| NNP
binding ||| S:919 E:926 ||| NN
.  ||| S:926 E:928 ||| .
The  ||| S:928 E:932 ||| DT
amount  ||| S:932 E:939 ||| NN
of  ||| S:939 E:942 ||| IN
phospholipids  ||| S:942 E:956 ||| NNS
( ||| S:956 E:957 ||| -LRB-
PL ||| S:957 E:959 ||| NNP
)  ||| S:959 E:961 ||| -RRB-
was  ||| S:961 E:965 ||| VBD
determined  ||| S:965 E:976 ||| VBN
by  ||| S:976 E:979 ||| IN
means  ||| S:979 E:985 ||| NNS
of  ||| S:985 E:988 ||| IN
mass  ||| S:988 E:993 ||| JJ
spectrometry ||| S:993 E:1005 ||| NN
.  ||| S:1005 E:1007 ||| .
Clotting  ||| S:1007 E:1016 ||| JJ
times  ||| S:1016 E:1022 ||| NNS
of  ||| S:1022 E:1025 ||| IN
platelet-rich  ||| S:1025 E:1039 ||| JJ
plasma  ||| S:1039 E:1046 ||| NNS
( ||| S:1046 E:1047 ||| -LRB-
PRP ||| S:1047 E:1050 ||| NNP
)  ||| S:1050 E:1052 ||| -RRB-
of  ||| S:1052 E:1055 ||| IN
newborns  ||| S:1055 E:1064 ||| NNS
stimulated  ||| S:1064 E:1075 ||| VBN
with  ||| S:1075 E:1080 ||| IN
ionophor  ||| S:1080 E:1089 ||| NN
showed  ||| S:1089 E:1096 ||| VBD
a  ||| S:1096 E:1098 ||| DT
significant  ||| S:1098 E:1110 ||| JJ
lower  ||| S:1110 E:1116 ||| JJR
reduction  ||| S:1116 E:1126 ||| NN
of  ||| S:1126 E:1129 ||| IN
clotting  ||| S:1129 E:1138 ||| JJ
time  ||| S:1138 E:1143 ||| NN
than  ||| S:1143 E:1148 ||| IN
in  ||| S:1148 E:1151 ||| IN
adult  ||| S:1151 E:1157 ||| NN
PRP ||| S:1157 E:1160 ||| NNP
.  ||| S:1160 E:1162 ||| .
No  ||| S:1162 E:1165 ||| DT
differences  ||| S:1165 E:1177 ||| NNS
in  ||| S:1177 E:1180 ||| IN
the  ||| S:1180 E:1184 ||| DT
support  ||| S:1184 E:1192 ||| NN
of  ||| S:1192 E:1195 ||| IN
TG  ||| S:1195 E:1198 ||| NNP
between  ||| S:1198 E:1206 ||| IN
neonatal  ||| S:1206 E:1215 ||| NN
and  ||| S:1215 E:1219 ||| CC
adult  ||| S:1219 E:1225 ||| NN
platelets  ||| S:1225 E:1235 ||| NNS
were  ||| S:1235 E:1240 ||| VBD
found  ||| S:1240 E:1246 ||| VBN
in  ||| S:1246 E:1249 ||| IN
neonatal  ||| S:1249 E:1258 ||| NN
or  ||| S:1258 E:1261 ||| CC
adult  ||| S:1261 E:1267 ||| NN
plasma  ||| S:1267 E:1274 ||| NN
by  ||| S:1274 E:1277 ||| IN
means  ||| S:1277 E:1283 ||| NNS
of  ||| S:1283 E:1286 ||| IN
CAT ||| S:1286 E:1289 ||| NNP
.  ||| S:1289 E:1291 ||| .
In  ||| S:1291 E:1294 ||| IN
the  ||| S:1294 E:1298 ||| DT
purified  ||| S:1298 E:1307 ||| JJ
system  ||| S:1307 E:1314 ||| NN
TG  ||| S:1314 E:1317 ||| NNP
was  ||| S:1317 E:1321 ||| VBD
increased  ||| S:1321 E:1331 ||| VBN
by  ||| S:1331 E:1334 ||| IN
adding  ||| S:1334 E:1341 ||| VBG
ionophor  ||| S:1341 E:1350 ||| JJ
stimulated  ||| S:1350 E:1361 ||| JJ
platelets  ||| S:1361 E:1371 ||| NN
but  ||| S:1371 E:1375 ||| CC
no  ||| S:1375 E:1378 ||| DT
difference  ||| S:1378 E:1389 ||| NN
was  ||| S:1389 E:1393 ||| VBD
evident  ||| S:1393 E:1401 ||| JJ
between  ||| S:1401 E:1409 ||| IN
stimulated  ||| S:1409 E:1420 ||| JJ
newborn  ||| S:1420 E:1428 ||| NN
and  ||| S:1428 E:1432 ||| CC
adult  ||| S:1432 E:1438 ||| NN
platelets ||| S:1438 E:1447 ||| NN
.  ||| S:1447 E:1449 ||| .
Flow  ||| S:1449 E:1454 ||| NN
cytometric  ||| S:1454 E:1465 ||| NN
analysis  ||| S:1465 E:1474 ||| NN
showed  ||| S:1474 E:1481 ||| VBD
no  ||| S:1481 E:1484 ||| DT
difference  ||| S:1484 E:1495 ||| NN
in  ||| S:1495 E:1498 ||| IN
annexin  ||| S:1498 E:1506 ||| JJ
V  ||| S:1506 E:1508 ||| NNP
binding  ||| S:1508 E:1516 ||| NN
between  ||| S:1516 E:1524 ||| IN
adult  ||| S:1524 E:1530 ||| NN
and  ||| S:1530 E:1534 ||| CC
newborn  ||| S:1534 E:1542 ||| JJ
platelets ||| S:1542 E:1551 ||| NN
.  ||| S:1551 E:1553 ||| .
The  ||| S:1553 E:1557 ||| DT
results  ||| S:1557 E:1565 ||| NNS
of  ||| S:1565 E:1568 ||| IN
mass  ||| S:1568 E:1573 ||| JJ
spectrometry  ||| S:1573 E:1586 ||| NN
showed  ||| S:1586 E:1593 ||| VBD
a  ||| S:1593 E:1595 ||| DT
very  ||| S:1595 E:1600 ||| RB
similar  ||| S:1600 E:1608 ||| JJ
amount  ||| S:1608 E:1615 ||| NN
and  ||| S:1615 E:1619 ||| CC
pattern  ||| S:1619 E:1627 ||| NN
of  ||| S:1627 E:1630 ||| IN
PL  ||| S:1630 E:1633 ||| NNP
of  ||| S:1633 E:1636 ||| IN
adult  ||| S:1636 E:1642 ||| NN
and  ||| S:1642 E:1646 ||| CC
newborns  ||| S:1646 E:1655 ||| JJ
platelets ||| S:1655 E:1664 ||| NN
.  ||| S:1664 E:1666 ||| .
Our  ||| S:1666 E:1670 ||| PRP$
results  ||| S:1670 E:1678 ||| NNS
do  ||| S:1678 E:1681 ||| VBP
not  ||| S:1681 E:1685 ||| RB
provide  ||| S:1685 E:1693 ||| VB
any  ||| S:1693 E:1697 ||| DT
evidence  ||| S:1697 E:1706 ||| NN
that  ||| S:1706 E:1711 ||| IN
a  ||| S:1711 E:1713 ||| DT
different  ||| S:1713 E:1723 ||| JJ
PL  ||| S:1723 E:1726 ||| NNP
content  ||| S:1726 E:1734 ||| NN
or  ||| S:1734 E:1737 ||| CC
expression  ||| S:1737 E:1748 ||| NN
of  ||| S:1748 E:1751 ||| IN
neonatal  ||| S:1751 E:1760 ||| JJ
platelets  ||| S:1760 E:1770 ||| NN
may  ||| S:1770 E:1774 ||| MD
alter  ||| S:1774 E:1780 ||| VB
TG  ||| S:1780 E:1783 ||| NNP
in  ||| S:1783 E:1786 ||| IN
neonates ||| S:1786 E:1794 ||| NN
.  ||| S:1794 E:1796 ||| .
